Skip to main content

Table 3 Patient characteristics

From: The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

Characteristics

Low (n = 17)

Intermediate (n = 70)

High (n = 66)

p-value*

Gender

   

0.17

   Male

13 (76%)

48 (69%)

37 (56%)

 

   Female

4 (24%)

22 (31%)

29 (44%)

 

Race

   

0.88

   White

15 (88%)

66 (94%)

63 (95%)

 

   Hispanic

1 (6%)

1 (1%)

1 (2%)

 

   Black

1 (6%)

2 (3%)

2 (3%)

 

   Other

0

1 (1%)

0

 

Neurologcal Function (Symptoms)

   

0.69

   None/Minor

7 (41%)

40 (57%)

37 (56%)

 

   Moderate

8 (47%)

25 (36%)

25 (38%)

 

   Major/Severe

2 (12%)

5 (7%)

3 (5%)

 

   Missing

0

0

1 (1%)

 

KPS

   

0.41

   ≤ 60

4 (24%)

7 (10%)

6 (9%)

 

   70–80

8 (47%)

29 (41%)

30 (45%)

 

   90–100

5 (29%)

34 (49%)

30 (45%)

 

Prior Surgery

   

0.84

   Biopsy

0

5 (7%)

5 (8%)

 

   Partial Resection

11 (65%)

42 (60%)

37 (56%)

 

   Total Resection

6 (35%)

22 (31%)

23 (35%)

 

   Unknown

0

1 (1%)

1 (1%)

 

RPA

   

0.08

   III

3 (18%)

20 (28%)

6 (9%)

 

   IV

7 (41%)

25 (36%)

31 (47%)

 

   V

7 (41%)

25 (36%)

29 (44%)

 

Study

    

   7401

6 (35%)

22 (31%)

10 (15%)

 

   7918

3 (18%)

4 (6%)

2 (3%)

 

   8302

4 (23%)

16 (23%)

10 (15%)

 

   8409

0

1 (1%)

0

 

   9006

1 (6%)

13 (19%)

18 (27%)

 

   9305

1 (6%)

1 (1%)

1 (1%)

 

   9602

2 (12%)

3 (4%)

8 (12%)

 

   9806

0

10 (14%)

17 (26%)

 
  1. * Chi-square Tests